Literature DB >> 21903592

Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation.

Qi Zhang1, Hui Xiao, Sergio C Chai, Quyen Q Hoang, Hua Lu.   

Abstract

Ribosomal protein L11 (RPL11) has been shown to activate p53 by binding to MDM2 and negating its p53 suppression activity in response to ribosomal stress. Although a mutation at Cys-305 within the zinc finger domain of MDM2 has been shown to drastically impair MDM2 interaction with RPL11 and thus escapes the inhibition by this ribosomal protein, it still remains elusive whether RPL11 inactivates MDM2 via direct action on this zinc finger domain and what is the chemical nature of this specific interaction. To define the roles of the MDM2 zinc finger in association with RPL11, we conducted hydrogen-deuterium exchange mass spectrometry, computational modeling, circular dichroism, and mutational analyses of the zinc finger domain of MDM2 and human RPL11. Our study reveals that RPL11 forms a stable complex with MDM2 in vitro through direct contact with its zinc finger. This binding is disrupted by single mutations of non-cysteine amino acids within the zinc finger domain of MDM2. Basic residues in RPL11 are crucial for the stable binding and RPL11 suppression of MDM2 activity toward p53. These results provide the first line of evidence for the specific interaction between RPL11 and the zinc finger of MDM2 via hydrophilic residues as well as a molecular foundation for better understanding RPL11 inhibition of MDM2 function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903592      PMCID: PMC3207392          DOI: 10.1074/jbc.M111.277012

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Mutual dependence of MDM2 and MDMX in their functional inactivation of p53.

Authors:  Jijie Gu; Hidehiko Kawai; Linghu Nie; Hiroyuki Kitao; Dmitri Wiederschain; Aart G Jochemsen; John Parant; Guillermina Lozano; Zhi-Min Yuan
Journal:  J Biol Chem       Date:  2002-04-12       Impact factor: 5.157

2.  Regulation of HDM2 activity by the ribosomal protein L11.

Authors:  Marion A E Lohrum; Robert L Ludwig; Michael H G Kubbutat; Mary Hanlon; Karen H Vousden
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

Review 3.  Lenalidomide for treatment of myelodysplastic syndromes: current status and future directions.

Authors:  Rami S Komrokji; Alan F List
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

4.  Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition.

Authors:  Mu-Shui Dai; Shelya X Zeng; Yetao Jin; Xiao-Xin Sun; Larry David; Hua Lu
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

5.  Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation.

Authors:  Sari Kurki; Karita Peltonen; Leena Latonen; Taija M Kiviharju; Päivi M Ojala; David Meek; Marikki Laiho
Journal:  Cancer Cell       Date:  2004-05       Impact factor: 31.743

6.  Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation.

Authors:  Krishna P Bhat; Koji Itahana; Aiwen Jin; Yanping Zhang
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

7.  Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5.

Authors:  Mu-Shui Dai; Hua Lu
Journal:  J Biol Chem       Date:  2004-08-11       Impact factor: 5.157

8.  Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.

Authors:  Yanping Zhang; Gabrielle White Wolf; Krishna Bhat; Aiwen Jin; Theresa Allio; William A Burkhart; Yue Xiong
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

9.  PAK1IP1, a ribosomal stress-induced nucleolar protein, regulates cell proliferation via the p53-MDM2 loop.

Authors:  Weishi Yu; Zhongwei Qiu; Na Gao; Liren Wang; Hengxiang Cui; Yu Qian; Li Jiang; Jian Luo; Zhengfang Yi; Hua Lu; Dali Li; Mingyao Liu
Journal:  Nucleic Acids Res       Date:  2010-11-21       Impact factor: 16.971

10.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  23 in total

1.  Ipr1 Regulation by Cyclic GMP-AMP Synthase/Interferon Regulatory Factor 3 and Modulation of Irgm1 Expression via p53.

Authors:  Fayang Liu; Hongni Xue; Jie Ke; Yongyan Wu; Kezhen Yao; Shuxin Liang; Aihua Xu; Yong Zhang
Journal:  Mol Cell Biol       Date:  2020-03-30       Impact factor: 4.272

2.  A single synonymous mutation determines the phosphorylation and stability of the nascent protein.

Authors:  Konstantinos Karakostis; Sivakumar Vadivel Gnanasundram; Ignacio López; Aikaterini Thermou; Lixiao Wang; Karin Nylander; Vanesa Olivares-Illana; Robin Fåhraeus
Journal:  J Mol Cell Biol       Date:  2019-03-01       Impact factor: 6.216

3.  Scission of the p53-MDM2 Loop by Ribosomal Proteins.

Authors:  Xiang Zhou; Jun-Ming Liao; Wen-Juan Liao; Hua Lu
Journal:  Genes Cancer       Date:  2012-03

Review 4.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

5.  Physical and functional interaction between ribosomal protein L11 and the tumor suppressor ARF.

Authors:  Mu-Shui Dai; Kishore B Challagundla; Xiao-Xin Sun; Lakshmi Reddy Palam; Shelya X Zeng; Ronald C Wek; Hua Lu
Journal:  J Biol Chem       Date:  2012-03-30       Impact factor: 5.157

6.  IκB kinase β (IKKβ) inhibits p63 isoform γ (TAp63γ) transcriptional activity.

Authors:  Jun-Ming Liao; Yu Zhang; Wenjuan Liao; Sheyla X Zeng; Xiaohua Su; Elsa R Flores; Hua Lu
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

7.  AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity.

Authors:  Guifen He; Yi-Wei Zhang; Jun-Ho Lee; Shelya X Zeng; Yunyuan V Wang; Zhijun Luo; X Charlie Dong; Benoit Viollet; Geoffrey M Wahl; Hua Lu
Journal:  Mol Cell Biol       Date:  2013-11-04       Impact factor: 4.272

Review 8.  Targeting p53-MDM2-MDMX loop for cancer therapy.

Authors:  Qi Zhang; Shelya X Zeng; Hua Lu
Journal:  Subcell Biochem       Date:  2014

9.  Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.

Authors:  X Zhou; Q Hao; Q Zhang; J-M Liao; J-W Ke; P Liao; B Cao; H Lu
Journal:  Cell Death Differ       Date:  2014-10-10       Impact factor: 15.828

10.  Mdm2 mediates FMRP- and Gp1 mGluR-dependent protein translation and neural network activity.

Authors:  Dai-Chi Liu; Joseph Seimetz; Kwan Young Lee; Auinash Kalsotra; Hee Jung Chung; Hua Lu; Nien-Pei Tsai
Journal:  Hum Mol Genet       Date:  2017-10-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.